In the last trading session, 0.12 million Eterna Therapeutics Inc (NASDAQ:ERNA) shares changed hands as the company’s beta touched 4.33. With the company’s per share price at $0.25 changed hands at $0.0 or 1.47% during last session, the market valuation stood at $13.29M. ERNA’s last price was a discount, traded about -948.0% off its 52-week high of $2.62. The share price had its 52-week low at $0.22, which suggests the last value was 12.0% up since then. When we look at Eterna Therapeutics Inc’s average trading volume, we note the 10-day average is 0.44 million shares, with the 3-month average coming to 721.79K.

Eterna Therapeutics Inc (NASDAQ:ERNA) trade information

Instantly ERNA was in green as seen at the end of in last trading. With action -1.22%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -85.59%, with the 5-day performance at -1.22% in the red. However, in the 30-day time frame, Eterna Therapeutics Inc (NASDAQ:ERNA) is -50.27% down. Looking at the short shares, we see there were 44458.0 shares sold at short interest cover period of 1.07 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0.06%.

ERNA Dividends

Eterna Therapeutics Inc is expected to release its next quarterly earnings report in January.

Eterna Therapeutics Inc (NASDAQ:ERNA)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 336.35% of Eterna Therapeutics Inc shares while 11.00% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at -4.65%.